<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655695/" ref="ordinalpos=4376&amp;ncbi_uid=6076755&amp;link_uid=PMC3655695" image-link="/pmc/articles/PMC3655695/figure/F3/" class="imagepopup">Figure 3. VA neuroprotection of α-Syn-overexpression in DA neurons is dependent on the ERK-MAPK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: Valproic Acid Ameliorates C. elegans Dopaminergic Neurodegeneration with Implications for ERK-MAPK <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody"><b>(A)</b> Cell-specific RNAi depletion of mek-2 negates the dopaminergic neuroprotection provided by VA at all concentrations of examined compared to empty vector (EV) control, where neuroprotection is still observed at 1, 2, and 3 mM VA. <b>(B)</b> Similar to A, mpk-1 depletion reverses neuroprotection of VA in dopaminergic neurons at 3 mM VA compared to EV control. P &lt; 0.05; Student’s t-test.</div></div>